A Functional Polymorphism in the Promoter Region of the Monoamine Oxidase A Gene Is Associated with the Cigarette Smoking Quantity in Alcohol-Dependent Heavy SmokersWiesbeck G.A.a · Wodarz N.b · Weijers H.-G.c · Dürsteler-MacFarland K.M.a · Wurst F.-M.a · Walter M.a · Boening J.d
aDivision of Substance Use Disorders, Psychiatric University Hospital Basel, Basel, Switzerland; bDivision of Substance Use Disorders, Psychiatric University Hospital Regensburg, Regensburg, cUniversity of Applied Police Sciences Aschersleben, Aschersleben, and dClinical Addiction Medicine, Psychiatric University Hospital Würzburg, Würzburg, Germany
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Tobacco smoking represents a leading cause of morbidity and mortality with a strong dose-response relation between the amount of smoking and the risks of tobacco-related diseases and death. The quantity that is smoked is determined predominantly by genetic factors. The present study examined whether there is an association between the quantity of cigarettes smoked and length variation of a functional 30-bp repeat polymorphism in the promoter region of the monoamine oxidase A (MAO-A) gene. The number of 30-bp repeats, which is associated with enzyme activity was assessed in 121 Caucasian men suffering from both alcohol and tobacco dependence. Analysis revealed that the highly active long allele (4 repeat) is associated with a significantly greater amount of cigarette smoking in comparison with the less active short allele (3 repeat). In a logistic regression model (dichotomized), smoking quantity was significantly predicted by MAO-A genotype while no other variable (age, height, body weight, frequency of smoking, quantity and frequency of alcohol consumption) met the significance level. Since tobacco smoke is a potent inhibitor of MAO-A, this result could be regarded as a genotype-related dosage effect. Taken together, in alcohol-dependent heavily smoking men there is evidence for a MAO-A gene-associated effect on the quantity that is smoked as reflected by the daily number of cigarettes consumed.
© 2006 S. Karger AG, Basel
World Health Organization: The World Health Report 2002. Geneva, World Health Organization, 2003.
- Edwards R: The problem of tobacco smoking. BMJ 2004;328:217–219.
- Koopmans JR, Slutske WS, Heath AC, Neale MC, Boomsma DI: The genetics of smoking initiation and quantity smoked in Dutch adolescent and young adult twins. Behav Genet 1999;29:383–393.
- Berlin I, Anthenelli RM: Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol 2001;4:33–42.
- Shih JC, Thompson RF: Monoamine oxidase in neuropsychiatry and behaviour. Am J Hum Genet 1999;65:593–598.
- Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A: The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse 2004;54:65–71.
- Shih JC, Chen K, Ridd MJ: Monoamine oxidase: from genes to behaviour. Annu Rev Neurosci 1999;22:197–217.
Carr LA, Basham JK: Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain. Life Sci 1991;48:1171–1177.
- Yu PH, Boulton AA: Irreversible inhibition of monoamine oxidase by some components of cigarette smoke. Life Sci 1987;41:675–682.
Pavlin R, Sket D: Effect of cigarette smoke on brain monoamine oxidase activity. Farm Vestn 1993;44:185–192.
- Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP: Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 1996;93:14065–14069.
- Berlin I, Said S, Spreux-Varoquaux O, Olivares R, Launay JM, Puech AJ: Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 1995a;38:756–761.
- Berlin I, Said S, Spreux-Varoquaux O, Launay JM, Olivares R, Millet V, Lecrubier Y, Puech AJ: A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther 1995b;58:444–452.
- Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC: cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 1988;85:4934–4938.
- Castro Costa MR, Edelstein SB, Castiglione CM, Chao H, Breakefield XO: Properties of monoamine oxidase in control and Lesch-Nyhan fibroblasts. Biochem Genet 1980;18:577–590.
- Hotamisligil GS, Breakefield XO: Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 1991;49:383–392.
- Ozelius L, Hsu YPP, Bruns G, Powell JF, Chen S, Weyler W, Utterback M, Zucker D, Haines J, Trofatter JA, Conneally PM, Gusella JF, Breakefield XO: Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism. Genomics 1988;3:53–58.
- Sabol SZ, Hu S, Hamer D: A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998;103:273–279.
- Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, et al: Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999;8:621–624.
- Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI, Reich T, Schmidt I, Schuckit MA: A new, semi-structured psychiatric interview for use in genetic linkage studies: a report of the reliability of the SSAGE. J Stud Alcohol 1994;55:149–158.
- Samochowiec J, Lesch KP, Rottmann M, Smolka M, Syagailo YV, Okladnova O, Rommelspacher H, Winterer G, Schmidt LG, Sander T: Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Res 1999;86:67–72.
- Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T, Hattori M, Hirose T, Nanko S: A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 1999;4:393–395.
- Anthenelli RM, Smith TL, Irwin MR, Schuckit MA: A comparative study of criteria for subgrouping alcoholics: the primary/secondary diagnostic scheme versus variations of the type 1/type 2 criteria. Am J Psychiatry 1994;151:1468–1474.
- Comings DE: Polygenic inheritance and micro/minisatellites. Mol Psychiatry 1998;3:21–31.
- Tivol EA, Shalish C, Schuback DE, Hsu YP, Breakefield XO: Mutational analysis of the human MAOA gene. Am J Med Genet 1996;67:92–97.
- Pontieri FE, Tanda G, Orzi F, Di Chiara G: Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996;382:255–257.
- Kidd KK: Association of disease with genetic markers: déjà vu all over again. Am J Med Genet 1993;48:71–73.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.